Rabbit anti-Drosophila melanogaster (Fruit fly) Drak Polyclonal Antibody |
|||
| MBS7189745-INQUIRE | MyBiosource | INQUIRE | Ask for price |
DRAK2-IN-1 |
|||
| HY-122629 | MedChemExpress | 10 mg | EUR 1385.3 |
|
Description: DRAK2-IN-1, compound 16, is a potent, selective and ATP-competitive DRAK2 inhibitor with IC50and Kivalues of 3 nM and 0.26 nM, respectively.DRAK2-IN-1 also has inbitory effect on DRAK1 (IC50=51 nM)[1]. |
|||
DRAK2-IN-1 |
|||
| MBS3842897-10mg | MyBiosource | 10mg | EUR 1905 |
DRAK2-IN-1 |
|||
| MBS3842897-1mg | MyBiosource | 1mg | EUR 430 |
DRAK2-IN-1 |
|||
| MBS3842897-5mg | MyBiosource | 5mg | EUR 1165 |
DRAK2-IN-1 |
|||
| MBS3842897-5x10mg | MyBiosource | 5x10mg | EUR 8565 |
DRAK2-IN-1 |
|||
| MBS5766532-5mg | MyBiosource | 5mg | EUR 915 |
DRAK2-IN-1 |
|||
| MBS5766532-5x5mg | MyBiosource | 5x5mg | EUR 3970 |
DRAK2-IN-1 |
|||
| T11094-10mg | TargetMol Chemicals | 10mg | Ask for price |
|
Description: DRAK2-IN-1 |
|||
DRAK2-IN-1 |
|||
| T11094-1g | TargetMol Chemicals | 1g | Ask for price |
|
Description: DRAK2-IN-1 |
|||
DRAK2-IN-1 |
|||
| T11094-1mg | TargetMol Chemicals | 1mg | Ask for price |
|
Description: DRAK2-IN-1 |
|||
DRAK2-IN-1 |
|||
| T11094-50mg | TargetMol Chemicals | 50mg | Ask for price |
|
Description: DRAK2-IN-1 |
|||
DRAK2-IN-1 |
|||
| T11094-5mg | TargetMol Chemicals | 5mg | Ask for price |
|
Description: DRAK2-IN-1 |
|||
DRAK1/2-IN-1 |
|||
| HY-152954 | MedChemExpress | Get quote | Ask for price |
|
Description: DRAK1/2-IN-1 (compound 10e) is an active dual DRAK1 and DRAK2 inhibitor with Kd values of 1 μM and 6 μM, respectively[1]. |
|||
DRAK1 (DAP Kinase-related Apoptosis-inducing Protein Kinase 1) |
|||
| MBS601136-005mg | MyBiosource | 0.05mg | EUR 490 |
DRAK1 (DAP Kinase-related Apoptosis-inducing Protein Kinase 1) |
|||
| MBS601136-5x005mg | MyBiosource | 5x0.05mg | EUR 2045 |
DRAK1, NT (DAP Kinase-related Apoptosis-inducing Protein Kinase 1) |
|||
| MBS613094-01mg | MyBiosource | 0.1mg | EUR 635 |
DRAK1, NT (DAP Kinase-related Apoptosis-inducing Protein Kinase 1) |
|||
| MBS613094-5x01mg | MyBiosource | 5x0.1mg | EUR 2700 |
DAP Kinase-Related Apoptosis-Inducing Protein Kinase 1 (DRAK1) Antibody |
|||
| abx033241-400l | Abbexa | 400 µl | EUR 518.75 |
DAP Kinase-Related Apoptosis-Inducing Protein Kinase 1 (DRAK1) Antibody |
|||
| abx033241-400ul | Abbexa | 400 ul | EUR 627.6 |
DAP Kinase-Related Apoptosis-Inducing Protein Kinase 1 (DRAK1) Antibody |
|||
| abx033241-80l | Abbexa | 80 µl | EUR 281.25 |
DRAK2 Peptide |
|||
| 42-010P | ProSci | 0.1 mg | EUR 405.6 |
|
Description: (IN) DRAK2 Peptide |
|||
DRAK1 Peptide |
|||
| 2147P | ProSci | 0.05 mg | EUR 197.7 |
|
Description: (NT) DRAK1 peptide |
|||
DRAK2 Peptide |
|||
| 2149P | ProSci | 0.05 mg | EUR 197.7 |
|
Description: (CT) DRAK2 peptide |
|||
DRAK2 Peptide |
|||
| MBS152546-005mg | MyBiosource | 0.05mg | EUR 175 |
DRAK2 Peptide |
|||
| MBS152546-5x005mg | MyBiosource | 5x0.05mg | EUR 770 |
DRAK1 Peptide |
|||
| MBS152587-005mg | MyBiosource | 0.05mg | EUR 175 |
DRAK1 Peptide |
|||
| MBS152587-5x005mg | MyBiosource | 5x0.05mg | EUR 770 |
DRAK1 Antibody |
|||
| 35391 | SAB | 100ul | EUR 479 |
DRAK1 Antibody |
|||
| 35391-100ul | SAB | 100ul | EUR 468 |
DRAK1 Antibody |
|||
| 35453 | SAB | 100ul | EUR 479 |
DRAK1 Antibody |
|||
| 35453-100ul | SAB | 100ul | EUR 468 |
DRAK1 antibody |
|||
| 22934 | SAB | 100ul | EUR 479 |
DRAK1 antibody |
|||
| 22934-100ul | SAB | 100ul | EUR 468 |
DRAK1 Antibody |
|||
| 24073-100ul | SAB | 100ul | EUR 468 |
DRAK1 Antibody |
|||
| 2147-002mg | ProSci | 0.02 mg | EUR 206.18 |
|
Description: DRAK1 Antibody: Apoptosis is mediated by death domain containing adapter molecules and a caspase family of proteases. Certain serine/threonine protein kinases, such as ASK-1 and RIP, are mediators of apoptosis. Two novel serine/threonine kinases that induce apoptosis were recently identified and designated DRAK1 and DRAK2 for DAP kinase-related apoptosis-inducing protein kinases. DRAKs contain an N-terminal kinase domain and a C-terminal regulation domain. Overexpression of DRAK1 induces apoptosis. DRAKs have high sequence homology to DAP and ZIP kinases, and they represent a novel family of serine/threonine kinases, which mediates apoptosis through their catalytic activities. DRAK1 is located in nucleus and the messenger RNA was ubiquitously expressed in human tissues. |
|||
DRAK1 Antibody |
|||
| 2147-01mg | ProSci | 0.1 mg | EUR 523.7 |
|
Description: DRAK1 Antibody: Apoptosis is mediated by death domain containing adapter molecules and a caspase family of proteases. Certain serine/threonine protein kinases, such as ASK-1 and RIP, are mediators of apoptosis. Two novel serine/threonine kinases that induce apoptosis were recently identified and designated DRAK1 and DRAK2 for DAP kinase-related apoptosis-inducing protein kinases. DRAKs contain an N-terminal kinase domain and a C-terminal regulation domain. Overexpression of DRAK1 induces apoptosis. DRAKs have high sequence homology to DAP and ZIP kinases, and they represent a novel family of serine/threonine kinases, which mediates apoptosis through their catalytic activities. DRAK1 is located in nucleus and the messenger RNA was ubiquitously expressed in human tissues. |
|||
DRAK2 Antibody |
|||
| 2149-002mg | ProSci | 0.02 mg | EUR 206.18 |
|
Description: DRAK2 Antibody: Apoptosis is mediated by death domain containing adapter molecules and a caspase family of proteases. Certain serine/threonine protein kinases, such as ASK-1 and RIP, are mediators of apoptosis. Two novel serine/threonine kinases that induce apoptosis were recently identified and designated DRAK1 and DRAK2 (for DAP kinase-related apoptosis-inducing protein kinases). DRAKs contain an N-terminal kinase domain and a C-terminal regulation domain. Overexpression of DRAK2 induces apoptosis. DRAKs have high sequence homology to DAP and ZIP kinases, and they represent a novel family of serine/threonine kinases, which mediates apoptosis through their catalytic activities. DRAK2 is located in nucleus and the messenger RNA was ubiquitously expressed in human tissues. |
|||
DRAK2 Antibody |
|||
| 2149-01mg | ProSci | 0.1 mg | EUR 523.7 |
|
Description: DRAK2 Antibody: Apoptosis is mediated by death domain containing adapter molecules and a caspase family of proteases. Certain serine/threonine protein kinases, such as ASK-1 and RIP, are mediators of apoptosis. Two novel serine/threonine kinases that induce apoptosis were recently identified and designated DRAK1 and DRAK2 (for DAP kinase-related apoptosis-inducing protein kinases). DRAKs contain an N-terminal kinase domain and a C-terminal regulation domain. Overexpression of DRAK2 induces apoptosis. DRAKs have high sequence homology to DAP and ZIP kinases, and they represent a novel family of serine/threonine kinases, which mediates apoptosis through their catalytic activities. DRAK2 is located in nucleus and the messenger RNA was ubiquitously expressed in human tissues. |
|||
DRAK2 Antibody |
|||
| 24074 | SAB | 100ul | EUR 479 |
DRAK2 Antibody |
|||
| 24074-100ul | SAB | 100ul | EUR 468 |
DRAK2 Antibody |
|||
| C21136-100ul | Assay Biotech | 100μl | EUR 217 |
|
Description: DRAK2 Rabbit Polyclonal Antibody |
|||
DRAK2 Antibody |
|||
| C21136-50ul | Assay Biotech | 50μl | EUR 143.5 |
|
Description: DRAK2 Rabbit Polyclonal Antibody |
|||
DRAK2, Antibody |
|||
| GWB-ECF989 | GenWay Biotech | 0.25 ml | Ask for price |
DRAK2, Antibody |
|||
| GWB-B078B8 | GenWay Biotech | 7 ml | Ask for price |
DRAK2, Antibody |
|||
| GWB-75A265 | GenWay Biotech | 1 ml | Ask for price |
DRAK1 Antibody |
|||
| MBS151045-01mg | MyBiosource | 0.1mg | EUR 445 |
DRAK1 Antibody |
|||
| MBS151045-5x01mg | MyBiosource | 5x0.1mg | EUR 1965 |
DRAK2 Antibody |
|||
| MBS151387-01mg | MyBiosource | 0.1mg | EUR 445 |
DRAK2 Antibody |
|||
| MBS151387-5x01mg | MyBiosource | 5x0.1mg | EUR 1965 |
DRAK1 Antibody |
|||
| MBS5312152-01mL | MyBiosource | 0.1mL | EUR 1070 |
DRAK1 Antibody |
|||
| MBS5312152-5x01mL | MyBiosource | 5x0.1mL | EUR 4655 |
DRAK2 Antibody |
|||
| MBS9404644-01mL | MyBiosource | 0.1mL | EUR 495 |
DRAK2 Antibody |
|||
| MBS9404644-5x01mL | MyBiosource | 5x0.1mL | EUR 2075 |
DRAK1 Antibody |
|||
| MBS9402242-01mL | MyBiosource | 0.1mL | EUR 495 |
DRAK1 Antibody |
|||
| MBS9402242-5x01mL | MyBiosource | 5x0.1mL | EUR 2075 |
DRAK1 Antibody |
|||
| MBS9402936-01mL | MyBiosource | 0.1mL | EUR 420 |
DRAK1 Antibody |
|||
| MBS9402936-5x01mL | MyBiosource | 5x0.1mL | EUR 1740 |
DRAK1 antibody |
|||
| MBS9406568-01mL | MyBiosource | 0.1mL | EUR 420 |
DRAK1 antibody |
|||
| MBS9406568-5x01mL | MyBiosource | 5x0.1mL | EUR 1740 |
DRAK1 Antibody |
|||
| MBS9406990-01mL | MyBiosource | 0.1mL | EUR 420 |
DRAK1 Antibody |
|||
| MBS9406990-5x01mL | MyBiosource | 5x0.1mL | EUR 1740 |
DRAK1 antibody |
|||
| 70R-13095 | Fitzgerald Industries International | 100 ul | Ask for price |
DRAK1 antibody (pAb) |
|||
| MBS388681-01mg | MyBiosource | 0.1mg | EUR 400 |
DRAK1 antibody (pAb) |
|||
| MBS388681-5x01mg | MyBiosource | 5x0.1mg | EUR 1735 |
DRAK2 antibody (pAb) |
|||
| MBS388683-01mg | MyBiosource | 0.1mg | EUR 400 |
DRAK2 antibody (pAb) |
|||
| MBS388683-5x01mg | MyBiosource | 5x0.1mg | EUR 1735 |
DRAK1 (N-term) Rabbit pAb |
|||
| E2620014 | EnoGene | 100ul | EUR 225 |
|
Description: Available in various conjugation types. |
|||
DRAK1 (STK17A), Active |
|||
| MBS517586-0005mg | MyBiosource | 0.005mg | EUR 320 |
DRAK1 (STK17A), Active |
|||
| MBS517586-001mg | MyBiosource | 0.01mg | EUR 390 |